Discovery of novel anti-infective agents.
Non-profit
antibacterial
antiparasitic
antiviral
coronavirus
global health
lead optimization
long acting injectables
medicinal chemistry
tuberculosis
Journal
Advances in pharmacology (San Diego, Calif.)
ISSN: 1557-8925
Titre abrégé: Adv Pharmacol
Pays: United States
ID NLM: 9015397
Informations de publication
Date de publication:
2024
2024
Historique:
medline:
22
7
2024
pubmed:
22
7
2024
entrez:
21
7
2024
Statut:
ppublish
Résumé
Academic and other non-profit institutions have a long-term vision to improve human health where commercial interests can be limited for profit organizations. Medicinal chemistry to these diseases with no commercial benefit needs is well suited in the academic environment and this chapter outlines some work conducted at Calibr-Skaggs around antibiotic drug development that has led to initiation of multiple clinical trials over the last decade.
Identifiants
pubmed: 39034055
pii: S1054-3589(24)00016-4
doi: 10.1016/bs.apha.2024.05.001
pii:
doi:
Substances chimiques
Anti-Infective Agents
0
Anti-Bacterial Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
39-117Informations de copyright
Copyright © 2024. Published by Elsevier Inc.